Table 1.
Treatment time after administration (min) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
T0 | T15 | T30 | T60 | T90 | T120 | T180 | T240 | T300 | T360 | |
Placebo | 35 (31–45) | 36 (30–46) | 37 (31–46) | 36 (30–45)a | 37 (31–45)a | 37 (30–45) | 36 (32–44) | 36 (31–45) | 35 (30–44) | 36 (32–44) |
Metoclopramide 0.25 mg Kg−1 | 36 (30–46) | 38 (33–51) | 42 (37–73)* | 46 (40–66)*b | 45 (37–56)*b | 41 (34–49)* | 45 (34–74)* | 39 (29–46) | 36 (32–61) | 35 (25–53) |
Ondansetron 0.15 mg Kg-1 (n = 10) | 37 (31–46) | 35 (27–45) | 43 (33–56)* | 43 (39–55)*a | 40 (34–51)*a | 43 (33–54)* | 44 (22–55)* | 38 (28–54) | 36 (31–55) | 35 (25–39) |
a,b Variables with different superscripts within the same time point significantly differ at p < 0.05.
Variables with (*) significantly differ at p < 0.05 over time.